Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Electrochemical Oxidation of Hexafluoropropylene Oxide Dimer Acid (GenX): Mechanistic Insights and Efficient Treatment Train with Nanofiltration.

Pica NE, Funkhouser J, Yin Y, Zhang Z, Ceres DM, Tong T, Blotevogel J.

Environ Sci Technol. 2019 Nov 5;53(21):12602-12609. doi: 10.1021/acs.est.9b03171. Epub 2019 Oct 24.

PMID:
31599577
2.

Discontinuation and Nonpublication of Randomized Clinical Trials Conducted in Children.

Pica N, Bourgeois F.

Pediatrics. 2016 Sep;138(3). pii: e20160223. doi: 10.1542/peds.2016-0223. Epub 2016 Aug 4.

3.

Closing the Brief Case: Safe To Go Back in the Water? Vibrio parahaemolyticus Wound Infection Associated with Brackish Water.

Brennan-Krohn T, Pica N, Sandora TJ, McAdam A.

J Clin Microbiol. 2016 Jun;54(6):1672. doi: 10.1128/JCM.02661-15. No abstract available.

4.

The Brief Case: Safe To Go Back in the Water? Vibrio parahaemolyticus Wound Infection Associated with Brackish Water.

Brennan-Krohn T, Pica N, Sandora TJ, McAdam A.

J Clin Microbiol. 2016 Jun;54(6):1414-1415. doi: 10.1128/JCM.02660-15. No abstract available.

5.

Ambient temperature and respiratory virus infection.

Pica N, Bouvier NM.

Pediatr Infect Dis J. 2014 Mar;33(3):311-3. doi: 10.1097/INF.0000000000000235. Review.

PMID:
24378933
6.

Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies.

Krammer F, Pica N, Hai R, Margine I, Palese P.

J Virol. 2013 Jun;87(12):6542-50. doi: 10.1128/JVI.00641-13. Epub 2013 Apr 10.

7.

Toward a universal influenza virus vaccine: prospects and challenges.

Pica N, Palese P.

Annu Rev Med. 2013;64:189-202. doi: 10.1146/annurev-med-120611-145115. Review.

PMID:
23327522
8.

A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates.

Krammer F, Margine I, Tan GS, Pica N, Krause JC, Palese P.

PLoS One. 2012;7(8):e43603. doi: 10.1371/journal.pone.0043603. Epub 2012 Aug 23.

9.

Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice.

Krammer F, Pica N, Hai R, Tan GS, Palese P.

J Virol. 2012 Oct;86(19):10302-7. doi: 10.1128/JVI.01336-12. Epub 2012 Jul 11.

10.

NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge.

Pica N, Langlois RA, Krammer F, Margine I, Palese P.

J Virol. 2012 Oct;86(19):10293-301. doi: 10.1128/JVI.01131-12. Epub 2012 Jul 11.

11.

Enhanced mammalian transmissibility of seasonal influenza A/H1N1 viruses encoding an oseltamivir-resistant neuraminidase.

Bouvier NM, Rahmat S, Pica N.

J Virol. 2012 Jul;86(13):7268-79. doi: 10.1128/JVI.07242-12. Epub 2012 Apr 24.

12.

Environmental factors affecting the transmission of respiratory viruses.

Pica N, Bouvier NM.

Curr Opin Virol. 2012 Feb;2(1):90-5. doi: 10.1016/j.coviro.2011.12.003. Epub 2012 Jan 4. Review.

13.

Attenuated influenza virus construct with enhanced hemagglutinin protein expression.

Maamary J, Pica N, Belicha-Villanueva A, Chou YY, Krammer F, Gao Q, García-Sastre A, Palese P.

J Virol. 2012 May;86(10):5782-90. doi: 10.1128/JVI.00190-12. Epub 2012 Mar 7.

14.

Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes.

Hai R, Krammer F, Tan GS, Pica N, Eggink D, Maamary J, Margine I, Albrecht RA, Palese P.

J Virol. 2012 May;86(10):5774-81. doi: 10.1128/JVI.00137-12. Epub 2012 Mar 7.

15.

Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses.

Pica N, Hai R, Krammer F, Wang TT, Maamary J, Eggink D, Tan GS, Krause JC, Moran T, Stein CR, Banach D, Wrammert J, Belshe RB, García-Sastre A, Palese P.

Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2573-8. doi: 10.1073/pnas.1200039109. Epub 2012 Jan 30.

16.

Transmission of influenza B viruses in the guinea pig.

Pica N, Chou YY, Bouvier NM, Palese P.

J Virol. 2012 Apr;86(8):4279-87. doi: 10.1128/JVI.06645-11. Epub 2012 Feb 1.

17.

The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses.

Pica N, Iyer A, Ramos I, Bouvier NM, Fernandez-Sesma A, García-Sastre A, Lowen AC, Palese P, Steel J.

J Virol. 2011 Dec;85(23):12825-9. doi: 10.1128/JVI.05930-11. Epub 2011 Sep 14.

18.

The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model.

Chou YY, Albrecht RA, Pica N, Lowen AC, Richt JA, García-Sastre A, Palese P, Hai R.

J Virol. 2011 Nov;85(21):11235-41. doi: 10.1128/JVI.05794-11. Epub 2011 Aug 31.

19.

Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes.

Wang TT, Tan GS, Hai R, Pica N, Ngai L, Ekiert DC, Wilson IA, García-Sastre A, Moran TM, Palese P.

Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18979-84. doi: 10.1073/pnas.1013387107. Epub 2010 Oct 18.

20.

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins.

Wang TT, Tan GS, Hai R, Pica N, Petersen E, Moran TM, Palese P.

PLoS Pathog. 2010 Feb 26;6(2):e1000796. doi: 10.1371/journal.ppat.1000796.

21.

Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.

Kopecky-Bromberg SA, Fraser KA, Pica N, Carnero E, Moran TM, Franck RW, Tsuji M, Palese P.

Vaccine. 2009 Jun 8;27(28):3766-74. doi: 10.1016/j.vaccine.2009.03.090. Epub 2009 Apr 23.

22.

Phosphatase-defective LEOPARD syndrome mutations in PTPN11 gene have gain-of-function effects during Drosophila development.

Oishi K, Zhang H, Gault WJ, Wang CJ, Tan CC, Kim IK, Ying H, Rahman T, Pica N, Tartaglia M, Mlodzik M, Gelb BD.

Hum Mol Genet. 2009 Jan 1;18(1):193-201. doi: 10.1093/hmg/ddn336. Epub 2008 Oct 11.

23.

Osmotically induced synthesis of the compatible solute hydroxyectoine is mediated by an evolutionarily conserved ectoine hydroxylase.

Bursy J, Pierik AJ, Pica N, Bremer E.

J Biol Chem. 2007 Oct 26;282(43):31147-55. Epub 2007 Jul 18.

24.

Expression of p63 in diffuse large B-cell lymphoma.

Hedvat CV, Teruya-Feldstein J, Puig P, Capodieci P, Dudas M, Pica N, Qin J, Cordon-Cardo C, Di Como CJ.

Appl Immunohistochem Mol Morphol. 2005 Sep;13(3):237-42.

PMID:
16082248
25.

Glucose 6-phosphate dehydrogenase is required for sucrose and trehalose to be efficient osmoprotectants in Sinorhizobium meliloti.

Barra L, Pica N, Gouffi K, Walker GC, Blanco C, Trautwetter A.

FEMS Microbiol Lett. 2003 Dec 12;229(2):183-8.

26.

Disaccharides as a new class of nonaccumulated osmoprotectants for Sinorhizobium meliloti.

Gouffi K, Pica N, Pichereau V, Blanco C.

Appl Environ Microbiol. 1999 Apr;65(4):1491-500.

Supplemental Content

Support Center